Robert Orlowski, MD, PhD

Dr. Robert Orlowski highlights strategies to prevent infections in multiple myeloma patients treated with linvoseltamab, emphasizing antiviral prophylaxis and IVIG use.

Robert Orlowski, MD, PhD, Florence Maude Thomas Cancer Research professor and chair, ad interim, Department of Lymphoma & Myeloma at The University of Texas MD Anderson Cancer Center, discusses remaining questions with multiple myeloma treatment.